vs
CLOVER HEALTH INVESTMENTS, CORP.（CLOV）与思佳讯（SWKS）财务数据对比。点击上方公司名可切换其他公司
思佳讯的季度营收约是CLOVER HEALTH INVESTMENTS, CORP.的1.3倍（$943.7M vs $749.2M），思佳讯净利率更高（3.8% vs 3.6%，领先0.1%），CLOVER HEALTH INVESTMENTS, CORP.同比增速更快（62.0% vs -1.0%），过去两年CLOVER HEALTH INVESTMENTS, CORP.的营收复合增速更高（45.0% vs 2.1%）
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
思佳讯是总部位于美国加利福尼亚州尔湾的半导体企业，公司股票在纳斯达克全球精选市场挂牌交易，股票代码为SWKS，同时也是标普500指数的成分股之一，在全球射频半导体领域拥有较高市场地位。
CLOV vs SWKS — 直观对比
营收规模更大
SWKS
是对方的1.3倍
$749.2M
营收增速更快
CLOV
高出63.0%
-1.0%
净利率更高
SWKS
高出0.1%
3.6%
两年增速更快
CLOV
近两年复合增速
2.1%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $749.2M | $943.7M |
| 净利润 | $27.3M | $35.6M |
| 毛利率 | — | 40.8% |
| 营业利润率 | 3.6% | 4.5% |
| 净利率 | 3.6% | 3.8% |
| 营收同比 | 62.0% | -1.0% |
| 净利润同比 | — | -48.2% |
| 每股收益（稀释后） | $0.05 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLOVSWKS
| Q2 26 | — | $943.7M | ||
| Q1 26 | $749.2M | $1.0B | ||
| Q4 25 | $487.7M | $1.1B | ||
| Q3 25 | $496.6M | — | ||
| Q2 25 | $477.6M | $965.0M | ||
| Q1 25 | $462.3M | $953.2M | ||
| Q4 24 | $337.0M | $1.1B | ||
| Q3 24 | $331.0M | $1.0B |
净利润CLOVSWKS
| Q2 26 | — | $35.6M | ||
| Q1 26 | $27.3M | $79.2M | ||
| Q4 25 | $-49.3M | $141.4M | ||
| Q3 25 | $-24.4M | — | ||
| Q2 25 | $-10.6M | $105.0M | ||
| Q1 25 | $-1.3M | $68.7M | ||
| Q4 24 | $-22.1M | $162.0M | ||
| Q3 24 | $-9.2M | $60.5M |
毛利率CLOVSWKS
| Q2 26 | — | 40.8% | ||
| Q1 26 | — | 41.3% | ||
| Q4 25 | — | 40.7% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 41.6% | ||
| Q1 25 | — | 41.1% | ||
| Q4 24 | — | 41.4% | ||
| Q3 24 | 24.5% | 41.9% |
营业利润率CLOVSWKS
| Q2 26 | — | 4.5% | ||
| Q1 26 | 3.6% | 10.0% | ||
| Q4 25 | -10.1% | 10.1% | ||
| Q3 25 | -4.9% | — | ||
| Q2 25 | -2.2% | 11.5% | ||
| Q1 25 | -0.3% | 10.2% | ||
| Q4 24 | -6.4% | 16.9% | ||
| Q3 24 | -2.7% | 5.8% |
净利率CLOVSWKS
| Q2 26 | — | 3.8% | ||
| Q1 26 | 3.6% | 7.6% | ||
| Q4 25 | -10.1% | 12.9% | ||
| Q3 25 | -4.9% | — | ||
| Q2 25 | -2.2% | 10.9% | ||
| Q1 25 | -0.3% | 7.2% | ||
| Q4 24 | -6.6% | 15.2% | ||
| Q3 24 | -2.8% | 5.9% |
每股收益（稀释后）CLOVSWKS
| Q2 26 | — | $0.24 | ||
| Q1 26 | $0.05 | $0.53 | ||
| Q4 25 | — | $0.95 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $0.70 | ||
| Q1 25 | — | $0.43 | ||
| Q4 24 | — | $1.00 | ||
| Q3 24 | — | $0.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $177.6M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $339.4M | $5.8B |
| 总资产 | $697.7M | $7.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLOVSWKS
| Q2 26 | — | — | ||
| Q1 26 | $177.6M | $1.6B | ||
| Q4 25 | $78.3M | $1.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | $194.5M | $1.7B | ||
| Q3 24 | $288.0M | $1.6B |
总债务CLOVSWKS
| Q2 26 | — | — | ||
| Q1 26 | — | $496.6M | ||
| Q4 25 | — | $496.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $496.2M | ||
| Q1 25 | — | $995.1M | ||
| Q4 24 | — | $994.7M | ||
| Q3 24 | — | $994.3M |
股东权益CLOVSWKS
| Q2 26 | — | $5.8B | ||
| Q1 26 | $339.4M | $5.8B | ||
| Q4 25 | $308.7M | $5.8B | ||
| Q3 25 | $340.9M | — | ||
| Q2 25 | $344.2M | $5.7B | ||
| Q1 25 | $336.1M | $5.9B | ||
| Q4 24 | $341.1M | $6.4B | ||
| Q3 24 | $342.2M | $6.3B |
总资产CLOVSWKS
| Q2 26 | — | $7.9B | ||
| Q1 26 | $697.7M | $7.9B | ||
| Q4 25 | $541.0M | $7.9B | ||
| Q3 25 | $559.7M | — | ||
| Q2 25 | $575.0M | $7.7B | ||
| Q1 25 | $583.7M | $7.9B | ||
| Q4 24 | $580.7M | $8.3B | ||
| Q3 24 | $653.0M | $8.3B |
负债/权益比CLOVSWKS
| Q2 26 | — | — | ||
| Q1 26 | — | 0.09× | ||
| Q4 25 | — | 0.09× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.09× | ||
| Q1 25 | — | 0.17× | ||
| Q4 24 | — | 0.16× | ||
| Q3 24 | — | 0.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $50.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 8.7% |
| 现金转化率经营现金流/净利润 | — | 1.41× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CLOVSWKS
| Q2 26 | — | $50.3M | ||
| Q1 26 | — | $395.5M | ||
| Q4 25 | $-66.9M | $200.0M | ||
| Q3 25 | $12.1M | — | ||
| Q2 25 | $5.4M | $314.2M | ||
| Q1 25 | $-16.3M | $409.4M | ||
| Q4 24 | $34.8M | $377.2M | ||
| Q3 24 | $50.0M | $476.1M |
自由现金流CLOVSWKS
| Q2 26 | — | — | ||
| Q1 26 | — | $339.0M | ||
| Q4 25 | $-69.0M | $144.0M | ||
| Q3 25 | $11.4M | — | ||
| Q2 25 | $4.8M | $252.7M | ||
| Q1 25 | $-16.5M | $370.9M | ||
| Q4 24 | $33.3M | $338.2M | ||
| Q3 24 | $49.6M | $393.3M |
自由现金流率CLOVSWKS
| Q2 26 | — | — | ||
| Q1 26 | — | 32.7% | ||
| Q4 25 | -14.1% | 13.1% | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 1.0% | 26.2% | ||
| Q1 25 | -3.6% | 38.9% | ||
| Q4 24 | 9.9% | 31.7% | ||
| Q3 24 | 15.0% | 38.4% |
资本支出强度CLOVSWKS
| Q2 26 | — | 8.7% | ||
| Q1 26 | — | 5.5% | ||
| Q4 25 | 0.4% | 5.1% | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.1% | 6.4% | ||
| Q1 25 | 0.0% | 4.0% | ||
| Q4 24 | 0.5% | 3.6% | ||
| Q3 24 | 0.1% | 8.1% |
现金转化率CLOVSWKS
| Q2 26 | — | 1.41× | ||
| Q1 26 | — | 4.99× | ||
| Q4 25 | — | 1.41× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.99× | ||
| Q1 25 | — | 5.96× | ||
| Q4 24 | — | 2.33× | ||
| Q3 24 | — | 7.87× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
